# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Wells Fargo analyst Brandon Couillard initiates coverage on Bruker (NASDAQ:BRKR) with a Overweight rating and announces Pric...
TD Cowen analyst Max Masucci maintains Bruker (NASDAQ:BRKR) with a Hold and lowers the price target from $74 to $72.
The minority investment aims to accelerate the growth and further expansion of NovAliX, particularly within Europe and the Unit...
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.52 per share which met the analyst consensus estimate. The company repo...
Citigroup analyst Patrick Donnelly maintains Bruker (NASDAQ:BRKR) with a Buy and lowers the price target from $95 to $80.
Goldman Sachs analyst Matthew Sykes maintains Bruker (NASDAQ:BRKR) with a Sell and lowers the price target from $72 to $60.